---
title: "NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) stock"
url: "https://aibio.space/companies/natural-alternatives-international/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "NATURAL ALTERNATIVES INTERNATIONAL INC (NASDAQ: NAII), United States. Listing facts, related biotech companies and news on aibio.space."
---

NAII NATURAL ALTERNATIVES INTERNATIONAL INC NASDAQ · United States

# NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) news

NATURAL ALTERNATIVES INTERNATIONAL INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NAII, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest NATURAL ALTERNATIVES INTERNATIONAL INC news

We have not published a story on NATURAL ALTERNATIVES INTERNATIONAL INC yet. When there is news, it will appear here.

## NATURAL ALTERNATIVES INTERNATIONAL INC at a glance

- **Ticker**: NAII

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jun 30, 2026**: $7.4 million

### Related companies

- [LFTD PARTNERS INC.](https://aibio.space/companies/lftd-partners/) OTC: LIFD
- [NEOGEN CORP](https://aibio.space/companies/neogen/) NASDAQ: NEOG
- [Quantum Cyber](https://aibio.space/companies/quantum-cyber-n-v/) NASDAQ: QUCY
- [Tilray Brands](https://aibio.space/companies/tilray-brands/) NASDAQ: TLRY
- [SERA PROGNOSTICS, INC.](https://aibio.space/companies/sera-prognostics/) NASDAQ: SERA
- [Embecta](https://aibio.space/companies/embecta/) NASDAQ: EMBC
- [PMGC Holdings](https://aibio.space/companies/pmgc/) NASDAQ: ELAB
- [TELA Bio](https://aibio.space/companies/tela-bio/) NASDAQ: TELA

### Also on NASDAQ

- [IDEXX LABORATORIES INC /DE](https://aibio.space/companies/idexx-laboratories-de/) IDXX
- [BioNexus Gene Lab](https://aibio.space/companies/bionexus-gene-lab/) BGLC
- [Immunocore Holdings](https://aibio.space/companies/immunocore/) IMCR
- [Cingulate](https://aibio.space/companies/cingulate/) CING
- [AETHLON MEDICAL INC](https://aibio.space/companies/aethlon-medical/) AEMD
- [DiaMedica Therapeutics](https://aibio.space/companies/diamedica-therapeutics/) DMAC

## What NATURAL ALTERNATIVES INTERNATIONAL INC does

Natural Alternatives International, Inc. is a leading formulator, manufacturer and marketer of nutritional supplements. Its stated vision is to enrich the world through the best of nutrition. Its primary business activity is private-label contract manufacturing for companies that market vitamins, minerals, herbal and other nutritional supplements, as well as other health care products. It also owns a patent estate for beta-alanine, sold directly and under license through the CarnoSyn, SR CarnoSyn, CarnoSyn 4X and TriBsyn trademarks. The company discontinued its SustainedRx and Perfect Synergy branded products during fiscal 2025 because the brand was not commercially successful. Its U.S. manufacturing is in Vista and Carlsbad, California, and its Swiss subsidiary operates a manufacturing facility in Manno, Switzerland. The facilities hold NSF Dietary Supplements Certification, NSF Certified for Sport and organic processor certifications.

| Product or program | What it is | Stage |
|---|---|---|
| CarnoSyn | Beta-alanine ingredient sold directly and licensed under patents and trademarks | marketed |
| SR CarnoSyn | Sustained-release beta-alanine ingredient and tablet products | marketed |
| CarnoSyn 4X | New form of CarnoSyn beta-alanine with pending patent applications | marketed |
| TriBsyn | Capsule product offered as business-to-business private label | marketed |

Summarised from the company's [10-K filed Sep 28, 2026](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/naii20260630_10k.htm).

## NATURAL ALTERNATIVES INTERNATIONAL INC annual financials

| Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 |
|---|---|---|
| Research and development | [$2.3 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) | [$1.8 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) |
| Net income (loss) | [-$20.7 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) | [-$13.6 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) |
| Cash from operations | [-$8.9 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) | [$5.9 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) |
| Cash and equivalents | [$7.4 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) | [$12.3 million](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/) |

Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $7.4 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about NATURAL ALTERNATIVES INTERNATIONAL INC

What is the ticker symbol of NATURAL ALTERNATIVES INTERNATIONAL INC?

NATURAL ALTERNATIVES INTERNATIONAL INC trades under the ticker NAII on NASDAQ.

Where is NATURAL ALTERNATIVES INTERNATIONAL INC listed?

NATURAL ALTERNATIVES INTERNATIONAL INC is listed on NASDAQ.

Which country or territory is NATURAL ALTERNATIVES INTERNATIONAL INC listed under?

Our directory records NATURAL ALTERNATIVES INTERNATIONAL INC under United States.

Does aibio.space cover NATURAL ALTERNATIVES INTERNATIONAL INC?

aibio.space lists NATURAL ALTERNATIVES INTERNATIONAL INC among 2,820 public biotech companies and publishes its news here as stories appear.

What does NATURAL ALTERNATIVES INTERNATIONAL INC develop?

Natural Alternatives International, Inc. is a leading formulator, manufacturer and marketer of nutritional supplements. Its stated vision is to enrich the world through the best of nutrition.

What is CarnoSyn from NATURAL ALTERNATIVES INTERNATIONAL INC?

CarnoSyn: Beta-alanine ingredient sold directly and licensed under patents and trademarks Stage: marketed.

What is SR CarnoSyn from NATURAL ALTERNATIVES INTERNATIONAL INC?

SR CarnoSyn: Sustained-release beta-alanine ingredient and tablet products Stage: marketed.

Is NATURAL ALTERNATIVES INTERNATIONAL INC profitable?

NATURAL ALTERNATIVES INTERNATIONAL INC reported a net loss of $20.7 million for the fiscal year ended Jun 30, 2026, and used $8.9 million of cash in operations, per its annual report to the SEC.

How much does NATURAL ALTERNATIVES INTERNATIONAL INC spend on research and development?

$2.3 million in the fiscal year ended Jun 30, 2026, per its annual report.

How much cash does NATURAL ALTERNATIVES INTERNATIONAL INC have?

$7.4 million in cash at Jun 30, 2026, per its 10-K.

## Investor discussion: NATURAL ALTERNATIVES INTERNATIONAL INC

Members talk about NATURAL ALTERNATIVES INTERNATIONAL INC (NAII). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at NATURAL ALTERNATIVES INTERNATIONAL INC, newest first. Each line links the filing it comes from.

1. 2026-09-28 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/787253/000143774926031343/naii20260630_10k.htm)
2. 2026-05-18 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/787253/000143774926017638/naii20260513_nt10q.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:NAII on TradingView](https://www.tradingview.com/symbols/NASDAQ-NAII/).

## Listing details

NATURAL ALTERNATIVES INTERNATIONAL INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NAII, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: NATURAL ALTERNATIVES INTERNATIONAL INC

- **Ticker**: NAII

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/natural-alternatives-international/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) stock", 2026-10-31, https://aibio.space/companies/natural-alternatives-international/
